Risk factors for high‐dose methotrexate associated toxicities in patients with primary central nervous system lymphoma
Journal of Clinical Pharmacy and Therapeutics · 2022-12 · 47 (12) · 2196-2204
DOI: 10.1111/jcpt.13791 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Pharmacy and Therapeutics, online erschienen am 19.10.2022. Verfasst von Kai Sun und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Huashan Hospital, Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Drug-Related Side Effects and Adverse Reactions, Acute Kidney Injury, Chemical and Drug Induced Liver Injury, Lymphoma. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 22 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Shanghai "Rising Stars of Medical Talent" Youth Development Program Clinical Pharmacist Program, Shanghai Municipal Health Commission Special Project for Clinical Research in Health Care Industry.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Huashan Hospital, Fudan University, Shanghai, China.
- Department of Pharmacy, Obstetrics and Gynecology Hospital, Fudan University, Shanghai, China.
- Department of Hematology, Huashan hospital, Fudan University, Shanghai, China.
ORCID-Profile: Kai Sun
Förderung
- National Natural Science Foundation of China
- Shanghai "Rising Stars of Medical Talent" Youth Development Program Clinical Pharmacist Program
- Shanghai Municipal Health Commission Special Project for Clinical Research in Health Care Industry
Zitieren
APA
Sun, K., Tao, H., Ding, T., Li, Z., Qiu, X., Zhong, M., & Wu, Z. (2022). Risk factors for high‐dose methotrexate associated toxicities in patients with primary central nervous system lymphoma. Journal of Clinical Pharmacy and Therapeutics, 47(12), 2196-2204. https://doi.org/10.1111/jcpt.13791
Vancouver
Sun K, Tao H, Ding T, Li Z, Qiu X, Zhong M, et al. Risk factors for high‐dose methotrexate associated toxicities in patients with primary central nervous system lymphoma. Journal of Clinical Pharmacy and Therapeutics. 2022;47(12):2196-2204. doi:10.1111/jcpt.13791
BibTeX
@article{Sun2022,
author = {Sun, Kai and Tao, Hongwei and Ding, Tianling and Li, Ziran and Qiu, Xiaoyan and Zhong, Mingkang and Wu, Zhuo},
title = {Risk factors for high‐dose methotrexate associated toxicities in patients with primary central nervous system lymphoma},
journal = {Journal of Clinical Pharmacy and Therapeutics},
year = {2022},
volume = {47},
number = {12},
pages = {2196--2204},
doi = {10.1111/jcpt.13791}
}
EUVIMED